Quantitative SNP-detection method for estimating HIV-1 replicative fitness: Application to protease inhibitor-resistant viruses

Microbiology and Immunology

Volumn 50, Issue 10, 2006, Pages 765-772

  Ibe, Shiro ^a   Fujisaki, Saeko ^a   Fujisaki, Seiichiro ^a   Morishita, Takayuki ^b   Kaneda, Tsuguhiro ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b AICHI PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Competitive growth assay; Protease inhibitor resistant HIV 1; Quantitative SNP detection; Viral replicative fitness

Indexed keywords

AMINO ACID; INDINAVIR; PROTEINASE INHIBITOR; SAQUINAVIR;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG INHIBITION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; KINETICS; MOLECULAR CLONING; NONHUMAN; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM; VIROGENESIS; VIRUS DETECTION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS SURVIVAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33750329418     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03852.x     Document Type: Article

References (22)

1. Clavel, F., Race, E., and Mammano, F. 2000. HIV drug resistance and viral fitness. Adv. Pharmacol. 49: 41-66.
2. Condra, J.H., Holder, D.J., Schleif, W.A., Blahy, O.M., Danovich, R.M., Gabryelski, L.J., Graham, D.J., Laird, D., Quintero, J.C., Rhodes, A., Robbins, H.L., Roth, E., Shivaprakash, M., Yang, T., Chodakewitz, J.A., Deutsch, R.J., Leavitt, R.Y., Massari, F.E., Mellors, J.W., Squires, K.E., Steigbigel, R.T., Teppler, H., and Emini, E.A. 1996. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J. Virol. 70: 8270-8276.
3. Condra, J.H., Schleif, W.A., Blahy, O.M., Gabryelski, L.J., Graham, D.J., Quintero, J.C., Rhodes, A., Robbins, H.L., Roth, E., Shivaprakash, M., Titus, D., Yang, T., Tepplert, H., Squires, K.E., Deutsch, P.J., and Emini, E.A. 1995. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374: 569-571.
4. Gulnik, S.V., Suvorov, L.I., Liu, B., Yu, B., Anderson, B., Mitsuya, H., and Erickson, J.W. 1995. Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure. Biochemistry 34: 9282-9287.
5. Harada, S., Koyanagi, Y., and Yamamoto, N. 1985. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
6. Holland, J.J., de la Torre, J.C., Clarke, D.K., and Duarte, E. 1991. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J. Virol. 65: 2960-2967.
7. Ibe, S., Hotta, N., Takeo, U., Tawada, Y., Mamiya, N., Yamanaka, K., Utsumi, M., and Kaneda, T. 2003. Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and usefulness of genotype testing. Microbiol. Immunol. 47: 499-505.
8. pol genes under highly active antiretroviral therapy. Microbiol. Immunol. 47: 71-79.
9. Jacobsen, H., Hänggi, M., Ott, M., Duncan, I.B., Owen, S., Andreoni, M., Vella, S., and Mous, J. 1996. In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies. J. Infect. Dis. 173: 1379-1387.
10. Jacobsen, H., Yasargil, K., Winslow, D.L., Craig, J.C., Kröhn, A., Duncan, I.B., and Mous, J. 1995. Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology 206: 527-534.
11. Mammano, F., Trouplin, V., Zennou, V., and Clavel, F. 2000. Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug. J. Virol. 74: 8524-8531.
12. Martinez-Picado, J., Savara, A.V., Shi, L., Sutton, L., and D'Aquila, R.T. 2000. Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutants. Virology 275: 318-322.
13. Martinez-Picado, J., Savara, A.V., Sutton, L., and D'Aquila, R.T. 1999. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. J. Virol. 73: 3744-3752.
14. Maschera, B., Furfine, E., and Blair, F.D. 1995. Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors. J. Virol. 69: 5431-5436.
15. Molla, A., Korneyeva, M., Gao, Q., Vasavanonda, S., Schipper, P.J., Mo, H.M., Markowitz, M., Chernyavskiy, T., Niu, P., Lyons, N., Hsu, A., Granneman, G.R., Ho, D.D., Boucher, C.A., Leonard, J.M., Norbeck, D.W., and Kempf, D.J. 1996. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat. Med. 2: 760-766.
16. Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., and De Clercq, E. 1988. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20: 309-321.
17. Pauwels, R., De Clercq, E., Desmyter, J., Balzarini, J., Goubau, P., Herdewijn, P., Vanderhaeghe, H., and Vandeputte, M. 1987. Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus. J. Virol. Methods 16: 171-185.
18. Pazhanisamy, S., Stuver, C.M., Cullinan, A.B., Margolin, N., Rao, B.G., and Livingston, D.J. 1996. Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants. J. Biol. Chem. 271: 17979-17985.
19. Quiñones-Mateu, M.E., and Arts, E.J. 2002. Fitness of drug resistant HIV-1: methodology and clinical implications. Drug Resist. Updat. 5: 224-233.
20. plus T-cell counts in HIV-infected patients. Ann. Intern. Med. 124: 1039-1050.
21. Shirasaka, T., Kavlick, M.F., Ueno, T., Gao, W.Y., Kojima, E., Alcaide, M.L., Chokekijchai, S., Roy, B.M., Arnold, E., Yarchoan, R., and Mitsuya, H. 1995. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. U.S.A. 92: 2398-2402.
22. Zhang, Y.M., Imamichi, H., Imamichi, T., Lane, H.C., Falloon, J., Vasudevachari, M.B., and Salzman, N.P. 1997. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J. Virol. 71: 6662-6670.